摘要
With the support by the National Natural Science Foundation of China,the research team directed by Prof.Yang YongQing(杨永清)at Shanghai University of Traditional Chinese Medicine,reported that transgelin-2 is a therapeutic target for asthmatic pulmonary resistance and its agonist can relax airway smooth muscle cells to provide therapeutic advantages for asthma,which was published in
With the support by the National Natural Science Foundation of China,the research team directed by Prof.Yang YongQing（杨永清）at Shanghai University of Traditional Chinese Medicine,reported that transgelin-2 is a therapeutic target for asthmatic pulmonary resistance and its agonist can relax airway smooth muscle cells to provide therapeutic advantages for asthma.
